Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder

MLA

Jane Hvarregaard Christensen, et al. “Using Genetic Drug-Target Networks to Develop New Drug Hypotheses for Major Depressive Disorder.” Translational Psychiatry, vol. 9, no. 1, June 2018. EBSCOhost, https://doi.org/10.1038/s41398-019-0451-4.

APA

Jane Hvarregaard Christensen, Zachary Gerring, Eske Derks, Christel Middeldorp, Per Qvist, Esben Agerbo, Gerome Breen, Lucía Colodro Conde, Héléna Gaspar, Christopher Hübel, Henriette Buttenschøn, Jakob Grove, & Bradley Webb. (2018). Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder. Translational Psychiatry, 9(1). https://doi.org/10.1038/s41398-019-0451-4

Chicago

Jane Hvarregaard Christensen, Zachary Gerring, Eske Derks, Christel Middeldorp, Per Qvist, Esben Agerbo, Gerome Breen, et al. 2018. “Using Genetic Drug-Target Networks to Develop New Drug Hypotheses for Major Depressive Disorder.” Translational Psychiatry 9 (1). doi:10.1038/s41398-019-0451-4.